Citation Impact
Citing Papers
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
2005 StandoutNatureNobel
Carbohydrate antigen expression in murine embryonic stem cells and embryos. I. Lacto and neo-lacto determinants
1993
Lipid rafts and signal transduction
2000 Standout
Protein A-conjugated luminescent gold nanodots as a label-free assay for immunoglobulin G in plasma
2011
Plasminogen‐activator inhibitor type 2 (PAI‐2) is a spontaneously polymerising SERPIN
1993
Chronic Venous Disease
2006 Standout
Antibody‐targeted superantigen therapy induces tumor‐infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma
1996
Pharmacokinetic aspects of biotechnology products
2004
Protein Dynamics in a Family of Laboratory Evolved Thermophilic Enzymes
2003 StandoutNobel
Synaptic transmission: A bidirectional and self-modifiable form of cell-cell communication
1993 StandoutNobel
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
A sensitive rosetting assay for detection of acetylcholine receptor antibodies using BC3H-1 cells: positive results in ‘antibody-negative’ myasthenia gravis
1990
Expression Cloning of a New Member of the ABO Blood Group Glycosyltransferases, iGb3 Synthase, That Directs the Synthesis of Isoglobo-glycosphingolipids
2000
Multiple sclerosis
2008 Standout
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Myasthenia Gravis
1994 Standout
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Neuroligin 1: A splice site-specific ligand for β-neurexins
1995 StandoutNobel
Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type‐2 and urokinases
1988
Cell-Associated Plasminogen Activation: Regulation and Physiological Functions
1988
The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer
2010
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
1998 StandoutNature
Regulatory T cells in transplantation tolerance
2003 StandoutNobel
Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG
1995
The role of backbone conformational heat capacity in protein stability: Temperature dependent dynamics of the B1 domain of Streptococcal protein G
2000
MHC Class II-Dependent Peptide Antigen Versus Superantigen Presentation to T Cells
1997
Complement
2001 Standout
High-affinity recombinant phage antibodies to the pan-carcinoma marker epithelial glycoprotein-2 for tumour targeting
1998
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
Mesoporous Materials for Drug Delivery
2007 Standout
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
2008
Asialo GM1+ CD8+ T cells play a critical role in costimulation blockade–resistant allograft rejection
1999
Amoebiasis
2003 Standout
Kinetics of inhibition of tissue‐type and urokinase‐type plasminogen activator by plasminogen‐activator inhibitor type 1 and type 2
1988
Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG
2004 Nature
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
Protein–Protein Docking with Simultaneous Optimization of Rigid-body Displacement and Side-chain Conformations
2003 StandoutNobel
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
GM3-enriched Microdomain Involved in Cell Adhesion and Signal Transduction through Carbohydrate-Carbohydrate Interaction in Mouse Melanoma B16 Cells
1998
Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme
1992 Standout
Complement-related proteins in pathogenic organisms
1994
Towards the Design of an Antibody that Recognises a Given Protein Epitope
1999 StandoutNobel
The lactosylceramide binding specificity of Helicobacter pylori
1998
Conformation of one- and two-chain high molecular weight urokinase analyzed by small-angle neutron scattering and vacuum ultraviolet circular dichroism
1991 StandoutNobel
Leishmania species: models of intracellular parasitism
1999
Plasminogen activator inhibitors
1987
Plasminogen activator inhibitor type‐1 : reactive center and amino‐terminal heterogeneity determined by protein and cDNA sequencing
1986
Reshaping Human Antibodies: Grafting an Antilysozyme Activity
1988 StandoutScienceNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Pathogenesis of Group A Streptococcal Infections
2000 Standout
Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage.
1992
Serpin Structure, Mechanism, and Function
2002 Standout
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
1986
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
1993 StandoutNobel
Protein L: An Immunoglobulin Light Chain-binding Bacterial Protein
1989
Plasminogen Activators, Tissue Degradation, and Cancer
1985 Standout
Synthetic Analogues of Glycosylphosphatidylinositol-Anchored Proteins and Their Behavior in Supported Lipid Bilayers
2007 StandoutNobel
Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.
1988
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens.
1986
Leishmania majorLACK Antigen Is Required for Efficient Vertebrate Parasitization
2003
Assembly of Bionanostructures onto β-Cyclodextrin Molecular Printboards for Antibody Recognition and Lymphocyte Cell Counting
2008
Advances in leishmaniasis
2005 Standout
Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor.
1991
Homogeneous Glycopeptides and Glycoproteins for Biological Investigation
2002 StandoutNobel
Identification and partial characterization of a lipophosphoglycan from a pathogenic strain of Entamoeba histolytica
1992
Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
1990 StandoutNobel
Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders: Structure−Activity Relationship
2004
Normal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
1990 StandoutScienceNobel
Endocytosis of urokinase-plasminogen activator inhibitor type 1 complexes bound to a chimeric transmembrane urokinase receptor.
1994 StandoutNobel
GPI anchor attachment is required for Gas1p transport from the endoplasmic reticulum in COP II vesicles.
1996 StandoutNobel
Different extracellular domains of the neural cell adhesion molecule (N-CAM) are involved in different functions.
1992
The Combinatorial Synthesis of Bicyclic Privileged Structures or Privileged Substructures
2003 Standout
Crystal Structures of Two Complexes of the Rare-Earth-DOTA-Binding Antibody 2D12.5: Ligand Generality from a Chiral System
2003
Helicobacter pylori Virulence and Genetic Geography
1999 StandoutScience
The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for Proteins
2008 StandoutNobel
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Replacing the complementarity-determining regions in a human antibody with those from a mouse
1986 StandoutNatureNobel
Tumors: Wounds That Do Not Heal
1986 Standout
Role of glycocalyx in leukocyte-endothelial cell adhesion
2002
A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties.
1986
cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta.
1987
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
1987
Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation
2001 StandoutNobel
Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.
1989 StandoutNobel
Human lymphocyte Hybridomas and Monoclonal Antibodies
1986
The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes
1993
Human monoclonal antibodies — production and potential
1984
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Works of Thomas Brodin being referenced
Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization
2007
Radio-Iodinated and Internally Labelled (35S) Igm Monoclonal Antibodies in a Syngenic Rat Model
1991
Changes in lipophosphoglycan and gene expression associated with the development ofLeishmania majorinPhlebotomus papatasi
1995
Allogeneic Heart Transplantation Activates Alloreactive NK Cells
1997
Novel isoglobo-neolacto-series hybrid glycolipid detected by a monoclonal antibody is a rat colon tumor-associated antigen
1989
The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis
2002
Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis
1990
Purification of a Specific Placental Plasminogen Activator Inhibitor by Monoclonal Antibody and Its Complex Formation with Plasminogen Activator
1985
Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.
1994
A monoclonal antibody specific for non-reducing terminal Gal?1-4Gal residues
1986
Quantitative analysis of rat Ig (sub) classes binding to cell surface antigens
1982
A monoclonal antibody that recognizes both leb and Y (Ley) antigens
1987
Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies.
1985
Antibody producing human-human hybridomas. I. Technical aspects
1983